Lung Cancer Screening Update | JoVE Visualize

Area of Science:

Pulmonary Medicine
Radiology
Public Health

Background:

Low-dose chest computed tomography (LDCT) for lung cancer screening has transitioned from research to clinical practice following US Preventive Services Task Force and Centers for Medicare and Medicaid Services recommendations.
Current lung cancer screening guidelines, based on the National Lung Screening Trial, identify only 27% of diagnosed lung cancer patients as eligible.
There is a critical need to expand screening eligibility and program reach to diverse socioeconomic and racial/ethnic groups.

Purpose of the Study:

To emphasize the essential components of successful lung cancer screening programs beyond imaging.
To highlight the importance of standardization in imaging, nodule management, and reporting for quality assurance and cost containment.
To advocate for optimized program design and patient eligibility to ensure screening benefits outweigh potential harms.

Main Methods:

Multidisciplinary approach integrating shared decision-making, standardized imaging and nodule management, smoking cessation interventions, and patient follow-up.
Analysis of current lung cancer screening guideline adherence and identification of gaps in patient eligibility.
Focus on systematic patient care, quality assurance, harm reduction, and healthcare cost containment.

Main Results:

Lung cancer screening programs require comprehensive strategies including clinical decision-making, standardized protocols, and patient support.
Significant disparities exist in current screening eligibility, with only 27% of lung cancer patients meeting established criteria.
Standardization of reporting and nodule management is crucial for consistent patient care and quality control.

Conclusions:

Effective lung cancer screening necessitates a holistic, multidisciplinary approach encompassing shared decision-making, standardized protocols, and robust follow-up.
Future efforts must focus on refining patient selection criteria and expanding program accessibility to underserved populations.
Optimizing lung cancer screening programs is vital to ensure that the benefits of early detection significantly outweigh the associated risks.